shareholdersunite.com

Opportunities in smallcaps

shareholdersunite.com header image 2

KORU Is Getting Tailwind From A Shift Away From IV And The Pandemic

June 13th, 2020 · No Comments

  • The company has developed unique technology for administering certain drugs subcutaneously at home, rather than through IV in a clinic.
  • The uptake of this is receiving an impulse as Grifols, a big name in IV, is shifting towards SC and the pandemic underlines the advantage of at home administration.
  • More PIDD and CIDP drugs are likely to become available for SC administration.
  • While we’re still bullish, the shares seem fully valued limiting the immediate upside.

Source: KORU Is Getting Tailwind From A Shift Away From IV And The Pandemic (NASDAQ:KRMD) | Seeking Alpha

Tags: KRMD